24.71  0 (0%)		05-15 16:00
Open: 24.71 High: 24.74 Volume: 592,052		Pre. Close: 24.71 Low: 24.71 Market Cap: 1,157(M)

Short term
Mid term
Targets	6-month :	29.09	1-year :	33.98
Resists	First :	24.9	Second :	29.09
Pivot price	24.7
Supports	First :	18.17	Second :	14.02
MAs	MA(5) :	24.73	MA(20) :	24.69
	MA(100) :	16.06	MA(250) :	13.47
MACD	MACD :	1.5	Signal :	1.9
%K %D	K(14,3) :	36.5	D(3) :	41.5
RSI	RSI(14): 87.5
52-week	High :	24.9	Low :	9.3

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ AVNS ] has closed below upper band by 46.3%. Bollinger Bands are 93.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	24.75 - 24.9	24.9 - 25.04
Low:	24.35 - 24.53	24.53 - 24.7
Close:	24.44 - 24.7	24.7 - 24.95

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Fri, 15 May 2026
New Strong Sell Stocks for May 15th - Yahoo Finance Singapore

Thu, 14 May 2026
Reasons to retain Avanos Medical stock in your portfolio for now - MSN

Tue, 12 May 2026
Avanos Medical (AVNS) director awarded 12,003 cash-settled RSUs - Stock Titan

Tue, 12 May 2026
Avanos Medical (NYSE: AVNS) director awarded 12,003 cash-settled restricted units - Stock Titan

Mon, 11 May 2026
Avanos Medical (NYSE:AVNS) Hits New 1-Year High - Here's Why - MarketBeat

Mon, 11 May 2026
A Look At Avanos Medical (AVNS) Valuation After Sharp Recent Share Price Gains - Sahm

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Devices
Shares Out	47 (M)
Shares Float	42 (M)
Held by Insiders	4.7 (%)
Held by Institutions	100.4 (%)
Shares Short	2,000 (K)
Shares Short P.Month	2,330 (K)

EPS	-1.58
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	16.75
Profit Margin	-10.4 %
Operating Margin	1.9 %
Return on Assets (ttm)	0.8 %
Return on Equity (ttm)	-9.1 %
Qtrly Rev. Growth	0.6 %
Gross Profit (p.s.)	7.58
Sales Per Share	15.02
EBITDA (p.s.)	1.16
Qtrly Earnings Growth	0 %
Operating Cash Flow	75 (M)
Levered Free Cash Flow	46 (M)

PE Ratio	-15.74
PEG Ratio	0
Price to Book value	1.47
Price to Sales	1.64
Price to Cash Flow	15.43

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.